Clinical Trial Update: Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder [Phase 3]

View source ↗

Summary

This document reports the completion and results posting of a Phase 3 efficacy trial of vortioxetine in adults with major depressive disorder. The study was spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Takeda | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-12-18